J. Mark Sloan

Assistant Professor

Education:

2008 Dana Farber/ Mass General Hospital, Fellowship in Hematolog/Oncology

2004 Yale New Haven Hospital, Internal Medicine Residency

2001 MD, Yale University School of Medicine

1996 BS, Haverford College

General field of research:

Hematology Oncology

Contact information:

Office
Phone: (617)-638 6428

Fax: (617)-638 1831

sloanjm@bu.edu

Recent publications:

Patel PV, Rennke HG, Sloan JM, Deangelo DJ, Charytan D A.  2009. Forgotten Cause of Kidney Injury in Chronic Myelomonocytic Leukemia.  American Journal of Kidney Disease Am J Kidney Dis.; 54(1):159-64.

Sloan JM, Ballen K.  2008.   Stem Cell Transplantation in Jehovah’s Witnesses: The Bloodless Transplant.  Bone Marrow Transplantation; 41(10): 837.

Sloan JM, Raje N.  2008.  Anemia and Erythropoeitic Growth factors in Multiple Myeloma, Ch 28 in Multiple Myeloma: Pursuing the Plasma Cell Ed. Sagar Lonial, Humana Press.

Sloan JM, Hochberg E, Hochberg F.  2007.  Beyond Methotrexate: Treatment of Residual Disease in Primary Central Nervous System Lymphoma.  The American Journal of Hematology/Oncology; volume 6 no 6.

Vinaya K, Sloan JM, White RI.  2004.  Reassessing bronchial artery embolotherapy with newer spherical embolic materials.  Journal of Vascular and Interventional Radiology; 15:304-305.

Sloan JM, Kershaw MH, Touloukian CE, Lapointe R, Robbins PF, Restifo NP, Hwu P.  2002.  MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells.  Cancer Gene Therapy; 9, 946-950.